Acorda Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Acorda Therapeutics, Inc.‘s stocks are currently a part of 29 hedge funds’ portfolios, which represents 87.9% of the total amount of its stocks outstanding. This makes up a total of 11.64M shares of Acorda Therapeutics, Inc.. Compared to the previous quarter, the number grew by 39.18% or 3.27M shares more. As for the holding position changes, 34.48% (10) of current hedge fund investors increased the number of shares held, 13.79% (4) of current holders sold a part of the shares held, and 17.24% (5) closed the holdings completely. 9 hedge funds are new holders of Acorda Therapeutics, Inc. stock in Q2 2022, it is 31.03% of total holders.
Hedge funds holding Acorda Therapeutics (Q3 2017 – Q2 2022)
| Q3 2017 | 155 |
|---|---|
| Q4 2017 | 153 |
| Q1 2018 | 164 |
| Q2 2018 | 180 |
| Q3 2018 | 175 |
| Q4 2018 | 178 |
| Q1 2019 | 183 |
| Q2 2019 | 159 |
| Q3 2019 | 146 |
| Q4 2019 | 118 |
| Q1 2020 | 101 |
| Q2 2020 | 76 |
| Q3 2020 | 58 |
| Q4 2020 | 44 |
| Q1 2021 | 28 |
| Q2 2021 | 28 |
| Q3 2021 | 29 |
| Q4 2021 | 28 |
| Q1 2022 | 26 |
| Q2 2022 | 29 |
Hedge funds changes in Acorda Therapeutics positions (Q3 2017 – Q2 2022)
| Q3 2017 | 18 | 65 | 43 | 17 | 12 |
|---|---|---|---|---|---|
| Q4 2017 | 21 | 56 | 53 | 24 | -1 |
| Q1 2018 | 29 | 56 | 43 | 16 | 20 |
| Q2 2018 | 30 | 65 | 57 | 14 | 14 |
| Q3 2018 | 22 | 58 | 58 | 26 | 11 |
| Q4 2018 | 24 | 67 | 56 | 20 | 11 |
| Q1 2019 | 26 | 82 | 40 | 22 | 13 |
| Q2 2019 | 16 | 79 | 39 | 37 | -12 |
| Q3 2019 | 19 | 57 | 42 | 31 | -3 |
| Q4 2019 | 14 | 41 | 43 | 42 | -22 |
| Q1 2020 | 13 | 33 | 35 | 28 | -8 |
| Q2 2020 | 17 | 14 | 27 | 42 | -24 |
| Q3 2020 | 4 | 11 | 29 | 22 | -8 |
| Q4 2020 | 11 | 7 | 14 | 26 | -14 |
| Q1 2021 | 25 | 2 | 1 | 40 | -40 |
| Q2 2021 | 6 | 7 | 11 | 6 | -2 |
| Q3 2021 | 6 | 8 | 9 | 5 | 1 |
| Q4 2021 | 4 | 12 | 5 | 5 | 2 |
| Q1 2022 | 4 | 1 | 8 | 6 | 7 |
| Q2 2022 | 9 | 10 | 4 | 5 | 1 |
Hedge funds changes in Acorda Therapeutics stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 6,720,000 | 8,278,000 |
|---|---|---|
| Q4 2017 | 4,384,000 | 12,672,000 |
| Q1 2018 | 17,191,000 | 39,541,000 |
| Q2 2018 | 18,719,000 | 28,471,000 |
| Q3 2018 | 43,885,000 | 17,992,000 |
| Q4 2018 | 37,199,000 | 15,164,000 |
| Q1 2019 | 2,402,000 | 5,052,000 |
| Q2 2019 | 1,819,000 | 1,206,000 |
| Q3 2019 | 810,000 | 1,200,000 |
| Q4 2019 | 665,000 | 633,000 |
| Q1 2020 | 79,000 | 3,765,000 |
| Q2 2020 | 101,000 | 2,406,000 |
| Q3 2020 | 103,000 | 793,000 |
| Q4 2020 | 226,000 | 102,000 |
| Q1 2021 | 1,194,000 | 924,000 |
| Q2 2021 | 749,000 | 893,000 |
| Q3 2021 | 898,000 | 491,000 |
| Q4 2021 | 179,000 | 203,000 |
| Q1 2022 | 63,000 | 6,000 |
| Q2 2022 | 10,000 | 0 |